Sikorski R - Search Results

1

Definition of an enhanced immune cell therapy in mice that can target stem-like lymphoma cells.

Contag CH, Sikorski R, Negrin RS, Schmidt T, Fan AC, Bachireddy P, Felsher DW, Thorne SH. Contag CH, et al. Among authors: sikorski r. Cancer Res. 2010 Dec 1;70(23):9837-45. doi: 10.1158/0008-5472.CAN-10-2650. Epub 2010 Oct 8. Cancer Res. 2010. PMID: 20935221 Free PMC article.

2

Targeting localized immune suppression within the tumor through repeat cycles of immune cell-oncolytic virus combination therapy.

Thorne SH, Liang W, Sampath P, Schmidt T, Sikorski R, Beilhack A, Contag CH. Thorne SH, et al. Among authors: sikorski r. Mol Ther. 2010 Sep;18(9):1698-705. doi: 10.1038/mt.2010.140. Epub 2010 Jul 6. Mol Ther. 2010. PMID: 20606649 Free PMC article.

3

Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1.

Huang B, Sikorski R, Kirn DH, Thorne SH. Huang B, et al. Among authors: sikorski r. Gene Ther. 2011 Feb;18(2):164-72. doi: 10.1038/gt.2010.121. Epub 2010 Aug 26. Gene Ther. 2011. PMID: 20739958

4

Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxviruses.

O'Gorman WE, Sampath P, Simonds EF, Sikorski R, O'Malley M, Krutzik PO, Chen H, Panchanathan V, Chaudhri G, Karupiah G, Lewis DB, Thorne SH, Nolan GP. O'Gorman WE, et al. Among authors: sikorski r. Cell Host Microbe. 2010 Aug 19;8(2):174-85. doi: 10.1016/j.chom.2010.07.008. Cell Host Microbe. 2010. PMID: 20709294 Free PMC article.

5

A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells.

Mutoh M, Lung FD, Long YQ, Roller PP, Sikorski RS, O'Connor PM. Mutoh M, et al. Among authors: sikorski rs. Cancer Res. 1999 Jul 15;59(14):3480-8. Cancer Res. 1999. PMID: 10416614

6

Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer.

Huang B, Sikorski R, Sampath P, Thorne SH. Huang B, et al. Among authors: sikorski r. J Immunother. 2011 Apr;34(3):289-96. doi: 10.1097/CJI.0b013e31820e1b0d. J Immunother. 2011. PMID: 21389869 Free PMC article.

7

Sun-related risk factors in melanoma-prone families with CDKN2A mutations.

Goldstein AM, Falk RT, Fraser MC, Dracopoli NC, Sikorski RS, Clark WH Jr, Tucker MA. Goldstein AM, et al. Among authors: sikorski rs. J Natl Cancer Inst. 1998 May 6;90(9):709-11. doi: 10.1093/jnci/90.9.709. J Natl Cancer Inst. 1998. PMID: 9586669 No abstract available.

8

Mutations associated with familial melanoma impair p16INK4 function.

Ranade K, Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA, Serrano M, Hannon GJ, Beach D, Dracopoli NC. Ranade K, et al. Among authors: sikorski rs. Nat Genet. 1995 May;10(1):114-6. doi: 10.1038/ng0595-114. Nat Genet. 1995. PMID: 7647780

9

The misidentification syndromes and source memory deficits with their neuroanatomical correlates from neuropsychological perspective.

Sikorski R, Sitek EJ. Sikorski R, et al. Behav Brain Sci. 2023 Nov 14;46:e376. doi: 10.1017/S0140525X23000274. Behav Brain Sci. 2023. PMID: 37961775

10

Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer.

Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, Juan T, Sikorski R, Suggs S, Radinsky R, Patterson SD, Chang DD. Amado RG, et al. Among authors: sikorski r. J Clin Oncol. 2023 Jun 20;41(18):3278-3286. doi: 10.1200/JCO.22.02758. J Clin Oncol. 2023. PMID: 37315390

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page